Sjögren's disease: open trials in Israel

• NCT07737743

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Kfar Saba · Petah Tikva · Ramat Gan · Tel Aviv · Tsrifin

  Registry updated 2026-10-28

• NCT06747949

  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  Trial Treatment · Phase 3 · Amgen

  Meir Medical Center, Kafr Saba · The Chaim Sheba Medical Center - PPDS, Ramat Gan

  Registry updated 2026-04-28

• NCT03473912

  Meir Medical Center Rheumatologic Biobank

  Research · Meir Medical Center

  Meir Medical Center, Kfar Saba

  Registry updated 2019-03-11

All Sjögren's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error